Clinical Trial Update: Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects [Phase 1]

View source ↗

Summary

This report provides a Phase 1 update on the safety and pharmacokinetics of multiple-dose YC-6 in healthy subjects, with ischemic stroke listed as the condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• YC-6

Snippet

Sponsor: Guangzhou Cellprotek Pharmaceutical Co., Ltd. | Conditions: Ischemic Stroke | Phase 1 | Status: UNKNOWN